CNS PHARMACEUTICALS INC's ticker is and the CUSIP is 18978H201. A total of 17 filers reported holding CNS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,451 | -51.4% | 6,772 | +70.4% | 0.00% | – |
| Q4 2023 | $5,048 | -6.6% | 3,975 | -16.1% | 0.00% | – |
| Q3 2023 | $5,404 | +22.8% | 4,740 | +140.1% | 0.00% | – |
| Q2 2023 | $4,402 | +36583.3% | 1,974 | -83.1% | 0.00% | – |
| Q1 2023 | $12 | +9.1% | 11,702 | +167.4% | 0.00% | – |
| Q4 2022 | $11 | – | 4,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|